Diversity in the acute CD8 T cell response to vaccinia virus in humans

被引:61
作者
Jing, LC
Chong, TM
McClurkan, CL
Huang, J
Story, BT
Koelle, DM
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[5] Benaroya Res Inst, Seattle, WA 98101 USA
关键词
D O I
10.4049/jimmunol.175.11.7550
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Orthopoxviruses have complex proteomes. Infection provokes a brisk CD8 response, which is required in some systems for recovery from primary infection. Little is known concerning the Ags and epitopes recognized by CD8 T cells. We examined the fine specificity of cloned and bulk human vaccinia-specific CD8 CTL by expressing polypeptide fragments from a library of vaccinia genomic DNA. This epitope discovery method emphasizes virus-specific biological activity, as the responder cells are all reactive with whole vaccinia virus. Sixteen novel epitopes, restricted by several HLA A and B alleles, were defined to the nomamer peptide level in diverse vaccinia open reading frames. An additional seven epitope were mapped to short regions of vaccinia proteins. Targets of the CD8 response included proteins assigned to structural, enzymatic, transcription factor, and immune evasion functions, and included members of all viral kinetic classes. Most epitopes were conserved in other orthopoxviruses. Responses to at least 18 epitopes were detected within a single blood sample, revealing a surprising degree of diversity. These epitopes will be useful in natural history studies of CD8 responses to vaccinia, a nonpersisting virus with long-term memory, and in the design and evaluation of attenuated and replication-incompetent vaccinia strains being tested for variola and monkeypox prevention and for the delivery of heterologous Ags.
引用
收藏
页码:7550 / 7559
页数:10
相关论文
共 54 条
[1]   The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses [J].
Antoine, G ;
Scheiflinger, F ;
Dorner, F ;
Falkner, FG .
VIROLOGY, 1998, 244 (02) :365-396
[2]   Vaccinia virus DNA replication: A short review [J].
Beaud, G .
BIOCHIMIE, 1995, 77 (10) :774-779
[3]   In vivo migration and function of transferred HIV-1-specific cytotoxic T cells [J].
Brodie, SJ ;
Lewinsohn, DA ;
Patterson, BK ;
Jiyamapa, D ;
Krieger, J ;
Corey, L ;
Greenberg, PD ;
Riddell, SR .
NATURE MEDICINE, 1999, 5 (01) :34-41
[4]   A DNA-LIGASE GENE IN THE COPENHAGEN STRAIN OF VACCINIA VIRUS IS NONESSENTIAL FOR VIRAL REPLICATION AND RECOMBINATION [J].
COLINAS, RJ ;
GOEBEL, SJ ;
DAVIS, SW ;
JOHNSON, GP ;
NORTON, EK ;
PAOLETTI, E .
VIROLOGY, 1990, 179 (01) :267-275
[5]   VACCINIA VIRUS-SPECIFIC CD8+ CYTOTOXIC LYMPHOCYTES-T IN HUMANS [J].
DEMKOWICZ, WE ;
ENNIS, FA .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1538-1544
[6]   Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines [J].
Drexler, I ;
Staib, C ;
Kastenmüller, W ;
Stevanovic, S ;
Schmidt, B ;
Lemonnier, FA ;
Rammensee, HG ;
Busch, DH ;
Bernhard, H ;
Erfle, V ;
Sutter, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :217-222
[7]   Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus [J].
Edghill-Smith, Y ;
Golding, H ;
Manischewitz, J ;
King, LR ;
Scott, D ;
Bray, M ;
Nalca, A ;
Hooper, JW ;
Whitehouse, CA ;
Schmitz, JE ;
Reimann, KA ;
Franchini, G .
NATURE MEDICINE, 2005, 11 (07) :740-747
[8]   Smallpox vaccination: Risk considerations for patients with atopic dermatitis [J].
Engler, RJM ;
Kenner, J ;
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (03) :357-365
[9]   Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells [J].
Fonteneau, JF ;
Kavanagh, DG ;
Lirvall, M ;
Sanders, C ;
Cover, TL ;
Bhardwaj, N ;
Larsson, M .
BLOOD, 2003, 102 (13) :4448-4455
[10]   Smallpox vaccination: A review, part II. Adverse events [J].
Fulginiti, VA ;
Papier, A ;
Lane, JM ;
Neff, JM ;
Henderson, DA .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :251-271